Successful Early Rescue With Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients With “No Washout Period”: A Real-World Clinical Experience in A Case Series and Literature Review. acmcr 2026, 10 (1), 1-5.